BACKGROUND: Egg-white ovomucoid, that is, Gal d 1, is associated with IgE-mediated allergic reactions in most egg-allergic children. Epitope-specific IgE levels have been correlated with the severity of egg allergy, while emerging evidence suggests that other antibody isotypes (IgG1 , IgG4 , IgA, and IgD) may have a protective function; yet, their epitope-specific repertoires and associations with atopic comorbidities have not been studied. METHODS: Bead-based epitope assay (BBEA) was used to quantitate the levels of epitope-specific (es)IgA, esIgE, esIgD, esIgG1 , and esIgG4 antibodies directed at 58 (15-mer) overlapping peptides, covering the entire sequence of ovomucoid, in plasma of 38 egg-allergic and 6 atopic children. Intraclass correlation (ICC) and coefficient of variation (CV) were used for the reliability assessment. The relationships across esIgs were evaluated using network analysis; linear and logistic regressions were used to compare groups based on egg allergy status and comorbidities. RESULTS: BBEA had high reliability (ICC >0.75) and low variability (CV <20%) and could detect known IgE-binding epitopes. Egg-allergic children had lower esIgA1 (P = .010) and esIgG1 (P = .016) and higher esIgE (P < .001) and esIgD (P = .015) levels compared to the atopic controls. Interestingly, within the allergic group, children with higher esIgD had decreased odds of anaphylactic reactions (OR =0.48, P = .038). Network analysis identified most associations between esIgE with either esIgG4 or esIgD; indicating that IgE-secreting plasma cells could originate from either sequential isotype switch from antigen-experienced intermediate isotypes or directly from the IgD+ B cells. CONCLUSIONS: Collectively, these data point toward a contribution of epitope-specific antibody repertoires to the pathogenesis of egg allergy.
BACKGROUND: Egg-white ovomucoid, that is, Gal d 1, is associated with IgE-mediated allergic reactions in most egg-allergicchildren. Epitope-specific IgE levels have been correlated with the severity of egg allergy, while emerging evidence suggests that other antibody isotypes (IgG1 , IgG4 , IgA, and IgD) may have a protective function; yet, their epitope-specific repertoires and associations with atopic comorbidities have not been studied. METHODS: Bead-based epitope assay (BBEA) was used to quantitate the levels of epitope-specific (es)IgA, esIgE, esIgD, esIgG1 , and esIgG4 antibodies directed at 58 (15-mer) overlapping peptides, covering the entire sequence of ovomucoid, in plasma of 38 egg-allergic and 6 atopic children. Intraclass correlation (ICC) and coefficient of variation (CV) were used for the reliability assessment. The relationships across esIgs were evaluated using network analysis; linear and logistic regressions were used to compare groups based on egg allergy status and comorbidities. RESULTS: BBEA had high reliability (ICC >0.75) and low variability (CV <20%) and could detect known IgE-binding epitopes. Egg-allergicchildren had lower esIgA1 (P = .010) and esIgG1 (P = .016) and higher esIgE (P < .001) and esIgD (P = .015) levels compared to the atopic controls. Interestingly, within the allergic group, children with higher esIgD had decreased odds of anaphylactic reactions (OR =0.48, P = .038). Network analysis identified most associations between esIgE with either esIgG4 or esIgD; indicating that IgE-secreting plasma cells could originate from either sequential isotype switch from antigen-experienced intermediate isotypes or directly from the IgD+ B cells. CONCLUSIONS: Collectively, these data point toward a contribution of epitope-specific antibody repertoires to the pathogenesis of egg allergy.
Authors: Nicholas J Osborne; Jennifer J Koplin; Pamela E Martin; Lyle C Gurrin; Adrian J Lowe; Melanie C Matheson; Anne-Louise Ponsonby; Melissa Wake; Mimi L K Tang; Shyamali C Dharmage; Katrina J Allen Journal: J Allergy Clin Immunol Date: 2011-03 Impact factor: 10.793
Authors: Stephanie A Leonard; Hugh A Sampson; Scott H Sicherer; Sally Noone; Erin L Moshier; James Godbold; Anna Nowak-Węgrzyn Journal: J Allergy Clin Immunol Date: 2012-08 Impact factor: 10.793
Authors: Timothy J Looney; Ji-Yeun Lee; Krishna M Roskin; Ramona A Hoh; Jasmine King; Jacob Glanville; Yi Liu; Tho D Pham; Cornelia L Dekker; Mark M Davis; Scott D Boyd Journal: J Allergy Clin Immunol Date: 2015-08-22 Impact factor: 10.793
Authors: Christopher C Udoye; Christina N Rau; Sarah M Freye; Larissa N Almeida; Sarah Vera-Cruz; Kai Othmer; Rabia Ü Korkmaz; Ann-Katrin Clauder; Timo Lindemann; Markus Niebuhr; Fabian Ott; Kathrin Kalies; Andreas Recke; Hauke Busch; Anke Fähnrich; Fred D Finkelman; Rudolf A Manz Journal: Mucosal Immunol Date: 2022-09-16 Impact factor: 8.701